# Milestone Scientific Inc.: Form 10-Q for the period ended Jun 30, 2012

- Company: [Milestone Scientific Inc.](/companies/mlss.md) (CIK 855683)
- Form: 10-Q
- Filed: 2012-08-09
- Accepted by EDGAR: Aug 9, 2012, 14:50 ET
- Period: 2012-06-30
- Accession: 0001193125-12-347153
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/855683/000119312512347153/d332269d10q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/855683/000119312512347153/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2012-06-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2012-04-01 to 2012-06-30 | $2.3m | us-gaap:SalesRevenueGoodsNet |
| Revenue | 6 months, 2012-01-01 to 2012-06-30 | $4.2m | us-gaap:SalesRevenueGoodsNet |
| Cost of revenue | 3 months, 2012-04-01 to 2012-06-30 | $854.0k | us-gaap:CostOfGoodsSold |
| Cost of revenue | 6 months, 2012-01-01 to 2012-06-30 | $1.5m | us-gaap:CostOfGoodsSold |
| Gross profit | 3 months, 2012-04-01 to 2012-06-30 | $1.5m | us-gaap:GrossProfit |
| Gross profit | 6 months, 2012-01-01 to 2012-06-30 | $2.7m | us-gaap:GrossProfit |
| Research and development | 3 months, 2012-04-01 to 2012-06-30 | $39.5k | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months, 2012-01-01 to 2012-06-30 | $78.8k | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months, 2012-04-01 to 2012-06-30 | $1.5m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months, 2012-01-01 to 2012-06-30 | $2.9m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2012-04-01 to 2012-06-30 | −$53.6k | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months, 2012-01-01 to 2012-06-30 | −$286.8k | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2012-04-01 to 2012-06-30 | $63.3k | us-gaap:InterestExpense |
| Interest expense | 6 months, 2012-01-01 to 2012-06-30 | $105.7k | us-gaap:InterestExpense |
| Net income | 3 months, 2012-04-01 to 2012-06-30 | −$164.5k | us-gaap:NetIncomeLoss |
| Net income | 6 months, 2012-01-01 to 2012-06-30 | −$519.7k | us-gaap:NetIncomeLoss |
| Operating cash flow | 6 months, 2012-01-01 to 2012-06-30 | −$109.0k | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months, 2012-01-01 to 2012-06-30 | $2.6k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | at 2012-06-30 | $121.8k | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2012-06-30 | $3.0m | us-gaap:AssetsCurrent |
| Total assets | at 2012-06-30 | $6.3m | us-gaap:Assets |
| Current liabilities | at 2012-06-30 | $3.9m | us-gaap:LiabilitiesCurrent |
| Shareholders' equity | at 2012-06-30 | $1.9m | us-gaap:StockholdersEquity |

## Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/855683/000119312512347153/d332269d10q.htm

Filed Aug 9, 2012.
Source: SEC EDGAR, the filing index for accession 0001193125-12-347153. Last ingested by Listed: Nov 14, 2026, 11:14 ET. No prices; not investment advice.
